← Leaderboards
Daniel Gallego-Perez
Ohio State University
$4,522,521
Attributed
$5,736,744
Total exposure
4
Grants
3
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.3M · FY2016–25$2.5M$1.9M$1.3M$625K$0
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$5,736,744 · 4
By mechanism
DP2$2,712,825 · 1
R01$1,863,780 · 1
DP1$736,639 · 1
R21$423,500 · 1
Top collaborators
- Kristin I Stanford3 shared
- Savita Khanna2 shared
- Cameron Lucian Rink2 shared
Most similar at Ohio State University
Same institution · by research overlap
- Jordan Taylor Moore$474,400
- Ly James Lee$3,875,706
- Sashwati Roy$8,043,268
- Kristin I Stanford$6,188,806
- Jose Javier Otero$3,018,480
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsTechnologyTissuesResponseBaseSourceFaceMediatingInnovationCell TherapyAlzheimer&AposSkinTransfectionObesityNanotechnologyPreventHealthcare SystemsExtracellular VesiclesGlucoseMethodologyNanotransfectionClinically RelevantResolutionViral
Grant awards (8)
Engineering the release of oxylipins through the skin$641,396
R01 · FY2025 · DK
Engineering the release of oxylipins through the skin$616,063
R01 · FY2024 · DK
Engineering the release of oxylipins through the skin$606,321
R01 · FY2023 · DK
Novel nanoscale approaches to whole tissue reprogramming$372,825
DP2 · FY2022 · EB · contact PI
Non-Viral Modulation of Cutaneous Tissue Plasticity as a Therapy for Diabetes$736,639
DP1 · FY2020 · DK · contact PI
Novel nanoscale approaches to whole tissue reprogramming$2,340,000
DP2 · FY2018 · EB · contact PI
Nanotechnology-based non-viral derivation of induced endothelium for ischemic disorders$192,500
R21 · FY2017 · NS · contact PI
Nanotechnology-based non-viral derivation of induced endothelium for ischemic disorders$231,000
R21 · FY2016 · NS · contact PI